INDICES
  • Samba 65 00% 56.65%
    Joga2002 635.254 50% 63.63%
    Bra52 69 23.145% -63.25%
    Joga2002 635.254 50% 63.63%
  • HangSang20 370 400% -20%
    NasDaq4 33 00% 36%
    S&P5002 60 50% 10%
    HangSang20 370 400% -20%
    Dow17 56.23 41.89% -2.635%
-

EghtesadOnline: Nasr Pharmaceutical Company and a Russian company named AVZ S-P have signed a contract for the joint production of livestock pharmaceutical products.

According to this agreement, Nasr and AVZ S-P will produce five products of veterinary medicine and supply them to the Russian domestic market or export them abroad to a third country. The contract was signed on July 23.

“Under this agreement, we will export the agreed upon drugs, including livestock antibiotics, to Russia as semi-finished products and will complete the production in cooperation with AVZ S-P,” Abdolrahim Motahari, the head of Nasr Pharmaceutical Company, was quoted as saying by IRNA.

“The five products to be jointly produced will be worth at least $700,000 per year. If the number reaches 20, the value of the contract will hit $2.5 million per year."

Nasr Pharmaceutical Company is the biggest producer of veterinary injectable medicines in Iran.

AVZ S-P is a Russian pharmaceutical company founded in 1993. For more than 20 years, the company is developing and producing remedies for curing livestock and pets.

 

Iran Russia